ArcticZymes Technologies ASA (AZT.OL)
NOK 16.85
(-0.88%)
NOK 16.85
(-0.88%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.38 NOK | -41.54% |
| 2022 | 0.65 NOK | -30.85% |
| 2021 | 0.94 NOK | -43.71% |
| 2020 | 1.67 NOK | 1213.33% |
| 2019 | -0.15 NOK | 50.0% |
| 2018 | -0.30 NOK | 47.37% |
| 2017 | -0.57 NOK | -21.28% |
| 2016 | -0.47 NOK | -17.5% |
| 2015 | -0.40 NOK | 23.08% |
| 2014 | -0.52 NOK | 13.33% |
| 2013 | -0.60 NOK | 29.41% |
| 2012 | -0.85 NOK | -21.43% |
| 2011 | -0.70 NOK | 40.68% |
| 2010 | -1.18 NOK | 71.29% |
| 2009 | -4.11 NOK | -90.28% |
| 2008 | -2.16 NOK | -163.41% |
| 2007 | -0.82 NOK | 34.4% |
| 2006 | -1.25 NOK | -50.6% |
| 2005 | -0.83 NOK | -453.33% |
| 2004 | -0.15 NOK | 72.73% |
| 2003 | -0.55 NOK | -1436.31% |
| 2002 | -0.04 NOK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.06 NOK | 57.32% |
| 2024 Q2 | 0.05 NOK | -19.74% |
| 2023 Q2 | 0.11 NOK | 10.44% |
| 2023 Q1 | 0.10 NOK | 378.85% |
| 2023 Q4 | 0.04 NOK | -67.0% |
| 2023 FY | - NOK | -41.54% |
| 2023 Q3 | 0.12 NOK | 9.09% |
| 2022 Q1 | 0.41 NOK | 36.67% |
| 2022 Q2 | 0.17 NOK | -58.54% |
| 2022 FY | - NOK | -30.85% |
| 2022 Q3 | 0.05 NOK | -70.59% |
| 2022 Q4 | 0.02 NOK | -58.4% |
| 2021 Q3 | 0.14 NOK | 55.56% |
| 2021 Q2 | 0.09 NOK | -77.5% |
| 2021 FY | - NOK | -43.71% |
| 2021 Q1 | 0.40 NOK | -47.37% |
| 2021 Q4 | 0.30 NOK | 114.29% |
| 2020 FY | - NOK | 1213.33% |
| 2020 Q4 | 0.76 NOK | 300.0% |
| 2020 Q3 | 0.19 NOK | -64.15% |
| 2020 Q2 | 0.53 NOK | 89.29% |
| 2020 Q1 | 0.28 NOK | 1112.12% |
| 2019 Q1 | -0.11 NOK | -149.43% |
| 2019 FY | - NOK | 50.0% |
| 2019 Q4 | 0.02 NOK | 498.28% |
| 2019 Q3 | -0.01 NOK | 85.5% |
| 2019 Q2 | -0.04 NOK | 63.64% |
| 2018 FY | - NOK | 47.37% |
| 2018 Q1 | -0.15 NOK | 6.25% |
| 2018 Q4 | -0.04 NOK | -156.4% |
| 2018 Q3 | -0.02 NOK | 82.23% |
| 2018 Q2 | -0.10 NOK | 35.47% |
| 2017 Q3 | -0.18 NOK | -63.64% |
| 2017 Q2 | -0.11 NOK | -10.0% |
| 2017 Q1 | -0.10 NOK | 44.44% |
| 2017 FY | - NOK | -21.28% |
| 2017 Q4 | -0.16 NOK | 11.11% |
| 2016 Q4 | -0.18 NOK | -28.57% |
| 2016 Q3 | -0.14 NOK | -180.0% |
| 2016 Q1 | -0.09 NOK | 47.06% |
| 2016 Q2 | -0.05 NOK | 44.44% |
| 2016 FY | - NOK | -17.5% |
| 2015 Q2 | -0.03 NOK | 57.14% |
| 2015 FY | - NOK | 23.08% |
| 2015 Q4 | -0.17 NOK | -54.55% |
| 2015 Q1 | -0.07 NOK | 41.67% |
| 2015 Q3 | -0.11 NOK | -266.67% |
| 2014 Q4 | -0.12 NOK | 14.29% |
| 2014 FY | - NOK | 13.33% |
| 2014 Q3 | -0.14 NOK | -133.33% |
| 2014 Q2 | -0.06 NOK | 68.42% |
| 2014 Q1 | -0.19 NOK | -35.71% |
| 2013 Q3 | -0.14 NOK | 0.0% |
| 2013 Q4 | -0.14 NOK | 0.0% |
| 2013 FY | - NOK | 29.41% |
| 2013 Q1 | -0.19 NOK | 17.39% |
| 2013 Q2 | -0.14 NOK | 26.32% |
| 2012 Q1 | -0.17 NOK | 22.73% |
| 2012 Q4 | -0.23 NOK | 4.17% |
| 2012 Q3 | -0.24 NOK | -20.0% |
| 2012 FY | - NOK | -21.43% |
| 2012 Q2 | -0.20 NOK | -17.65% |
| 2011 Q4 | -0.22 NOK | -15.79% |
| 2011 Q1 | -0.10 NOK | -22.1% |
| 2011 Q2 | -0.18 NOK | -80.0% |
| 2011 Q3 | -0.19 NOK | -5.56% |
| 2011 FY | - NOK | 40.68% |
| 2010 Q4 | -0.08 NOK | 74.41% |
| 2010 Q2 | -0.24 NOK | 54.72% |
| 2010 Q1 | -0.53 NOK | 0.0% |
| 2010 Q3 | -0.32 NOK | -33.33% |
| 2010 FY | - NOK | 71.29% |
| 2009 FY | - NOK | -90.28% |
| 2008 FY | - NOK | -163.41% |
| 2007 FY | - NOK | 34.4% |
| 2006 FY | - NOK | -50.6% |
| 2005 FY | - NOK | -453.33% |
| 2004 FY | - NOK | 72.73% |
| 2003 FY | - NOK | -1436.31% |
| 2002 FY | - NOK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Arctic Bioscience AS | -1.79 NOK | 121.229% |
| Aqua Bio Technology ASA | -0.99 NOK | 138.384% |
| BerGenBio ASA | -13.30 NOK | 102.857% |
| Hofseth BioCare ASA | -0.27 NOK | 240.741% |
| PCI Biotech Holding ASA | -0.54 NOK | 170.37% |
| Thor Medical ASA | -0.03 NOK | 1294.969% |
| Ultimovacs ASA | -5.50 NOK | 106.909% |